Animal disease outbreaks have been shown to cause major economic losses over the centuries. Several diseases such as walking pneumonia, anaplasmosis, aspergilloma, athlete's foot, babesiosis, bacteremia, brucellosis, campylobacteriosis, candidemia, candidiasis, cellulitis, cholangitis, cholecystitis, clostridial enterotoxicosis, clostridiosis, colitis, cryptosporidiosis, dermatophytosis, diarrhoea, endocarditis, epizootic hemorrhagic disease, esophagitis, foot and mouth disease, fungal infection of nail, jock itch, and ringworm, fungemia, gastroenteritis, giardiasis, hemolytic-uremic syndrome, haemorrhage, hepatitis E, intra-abdominal infection, meningitis, minor skin infections, neonatal meningitis, neosporosis, osteomyelitis, pelvic inflammatory diseases, peritonitis, pneumonia, prostatitis, pulmonary infections, sepsis, septicemia, skin infections, tinea or ringworm, toxic shock syndrome, toxoplasmosis, traveler's diarrhea, trichinosis, tuberculosis, typhoid, urinary and septic infections, west nile fever, wound infection and so on affect multiple animals. An early detection system enables the timely detection and identification of an incursion or emergence/re-emergence of a disease/infection in a given country, zone or compartment prevent the disease outbreak. The exquisite specificity of antigen-antibody interactions has led to the development of a variety of immunologic assays, which can be used to detect the presence of either antibody or antigen. Genemedi developed the antigen and antibody to detect the animal diseases. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Infectious Disease Pathogen Classification:

Anaplasma phagocytophilum Leptospira Anaplasma platys Brucella abortus/Brucella melitensis Pasteurella multocida Babesia caballi Chicken Astrovirus Staphylococcus saprophyticus Trichinella Tritrichomonas suis Trichophyton mentagrophytes Giardia Salmonella spp Mycoplasma Proteus Pseudomonas Dermatophytes Klebsiella pneumoniae West Nile Virus campylobacter spp Hepatitis E Pestivirus Brucella Mycobacterium avium Neospora caninum Aspergillus brasiliensis Burkholderia mallei Anaplasma phagocytophilium Citrobacter freudii Rift Valley fever Virus Aphthovirus/Foot and Mouth Disease Virus(FMDV) Borrelia burgdorferi sensu lato(B.b.s.l., genospecies B.b. sensu stricto, B. garinii, B. afzelii) i Cryptosporidium parvum Clostridium perfringens Babesia canis Babesia gibsoni Clostridium difficile Giardia lamblia Tritrichomonas galliniae Clostridium botulinum type C and D Borrelia burgdorferi sensu lato Candida albicans Candida glabrata Candida krusei Candida tropicalis Enterococcus faecalis Epizootic haemorrhagic disease virus Saccharomyces cerevisiae Salmonella enterica subsp. enterica Salmonella enterica subsp. Typhimurium Staphylococcus aureus Toxoplasma gondii Trichophyton rubrum Trichophyton tonsurans Escherichia Coli Escherichia coli O157:H7

Veterinary diagnostic metabolite biomarkers are specific molecules found in biological samples of animals that are indicative of a particular disease or condition. The identification and measurement of these biomarkers through metabolomics analysis provide important information for veterinarians to diagnose the disease and monitor its progression. These metabolites serve as the molecular fingerprints of the physiological state of the animal and can be used as biomarkers for disease diagnosis. The discovery of veterinary diagnostic metabolite biomarkers has great potential in clinical veterinary medicine. These biomarkers can be used for early detection, accurate diagnosis, and monitoring of the progression of diseases in animals, including cancer, diabetes, liver disease, and other metabolic disorders. As a result, metabolomics analysis is becoming increasingly important in veterinary medicine and holds promise for improving animal health. GeneMedi offers paired antibodies (monoclonal antibody, mab) and antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for VT-metabolite Biomarker rapid test kit in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immunoassay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.

VT-metabolite Biomarker Classification:

TFF2 TFF3 MPA CCP SAH HCY RAA/Aldo Digoxin HFABP LCA cholanoic acid HA CG cr G17 TFF1 rT3 25-OH-(VD3+VD2) 25-OH-VD 25-OH-VD-3 LP-PLA2 RBP4 DHEA DEX Calcitonin Cortisol Testosterone PG EPO Progesterone LH Prolactin E1 E2/E3 DES/HES Bisphenol A Thyroxin T4 Forchlorfenuron Norethisterone Flugestone Acetate Thyroxin T3 IGFBP-1 TBG FA VPA Paracetamol SA

Host classification Cat No. Product Name Products Type Specific Host Pathogen Name Target Disease Bioactivity validation Inquiry Order

6th Floor, Building No.2, Kangxin Road 3377, Shanghai, China
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
Chinese Website